Interleukin (IL)–12 and IL‐23 Are Key Cytokines for Immunity against Salmonella in Humans

Calman A. MacLennan, Claire Fieschi, David A. Lammas, Capucine Pïcard, Susan E. Dorman, Özden Sanal, Jenny MacLennan, Steven M. Holland, Tom H. M. Ottenhoff, Jean‐Laurent Casanova,

The Journal of Infectious Diseases · 2004 · 200 citations · 6 references

DOIFull text

Open access

Concepts

Abstract

Patients with inherited deficiency of the interleukin (IL)-12/IL-23-interferon (IFN)- gamma axis show increased susceptibility to invasive disease caused by the intramacrophage pathogens salmonellae and mycobacteria. We analyzed data on 154 patients with such deficiency. Significantly more patients with IL-12/IL-23-component deficiency had a history of salmonella disease than did those with IFN- gamma -component deficiency. Salmonella disease was typically severe, extraintestinal, and caused by nontyphoidal serovars. These findings strongly suggest that IL-12/IL-23 is a key cytokine for immunity against salmonella in humans and that IL-12/IL-23 mediates this protective effect partly through IFN- gamma -independent pathways. Investigation of the IL-12/IL-23-IFN- gamma axis should be considered in patients with invasive salmonella disease.

References

6